AZoSensors on MSN4h
AI-Powered Wearable Device Shows Promise in Reducing Nighttime Scratching for Atopic Dermatitis PatientsThe AI-driven wearable sensor demonstrates high accuracy in reducing nighttime scratching for atopic dermatitis, improving ...
Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., ...
Cold weather, dry air, an overactive immune system or our modern lifestyle. The causes may vary, but an increasing number of ...
The FDA has granted Fast Track designation to rezpegaldesleukin for the treatment of moderate to severe atopic dermatitis.
US FDA grants fast track designation to Nektar Therapeutics’ rezpegaldesleukin to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 11, 2025, 16:00 Hrs ...
Silverberg, J.I., Rosmarin, D., Chovatiya, R. et al. The regulatory T cell-selective interleukin-2 receptoragonist rezpegaldesleukin in the treatment of inflammatory ...
Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic ...
Your indoor versus outdoor environment could have an even bigger impact on your eczema symptoms than you realize.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback